Unknown

Dataset Information

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study.


ABSTRACT:

Objective

Electroconvulsive therapy is effective in treatment-resistant schizophrenia (TRS) but use is limited due to stigma and concerns around cognitive adverse effects. Magnetic seizure therapy (MST) is a promising new neuromodulation technique that uses transcranial magnetic stimulation to induce therapeutic seizures. Studies of MST in depression have shown clinical improvement with a favorable adverse effect profile. No studies have examined the clinical utility of MST in schizophrenia.

Methods

We conducted an open-label pilot clinical trial of MST in eight TRS patients. Up to 24 MST treatments were delivered depending on treatment response. We assessed clinical outcome through the Brief Psychiatric Rating Scale (BPRS) and the Quality of Life Enjoyment and Satisfaction

SUBMITTER: Tang VM 

PROVIDER: S-EPMC5775974 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature